TRIM5 and HIV-1 infection: Similar to their results, siRNA targeting TRIM5 increased permissiveness to HIV-1 infection up to 20 fold (Figure 3B), which is roughly eight-fold more permissiveness than we observed in AGM cells transfected with the BTBD2 shRNA plasmid.